Welcome to LookChem.com Sign In|Join Free
  • or
Hemoglobin J Antakya is a rare mutation of the hemoglobin protein, which is essential for oxygen transport in the blood. This mutation causes a structural alteration in the hemoglobin molecule, resulting in reduced oxygen-binding capacity and possible red blood cell instability. The condition may lead to symptoms of anemia and an increased risk of complications such as jaundice and gallstones. The mutation is named after the city of Antakya in Turkey, where it was first identified. Understanding the genetic and biochemical characteristics of Hemoglobin J Antakya is vital for diagnosing and managing this uncommon hemoglobin disorder.

59650-79-2

Post Buying Request

59650-79-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59650-79-2 Usage

Uses

Hemoglobin J Antakya is primarily used in the following applications:
Used in Medical Research:
Hemoglobin J Antakya serves as a subject of study for medical researchers to better understand the genetic and biochemical properties of hemoglobin mutations. This knowledge aids in the development of diagnostic methods and treatment strategies for individuals affected by this rare disorder.
Used in Diagnostic Laboratories:
Hemoglobin J Antakya is utilized in diagnostic laboratories for identifying and confirming the presence of this specific mutation in patients exhibiting symptoms of anemia or other related complications. Accurate diagnosis is crucial for providing appropriate medical care and management.
Used in Genetic Counseling:
Hemoglobin J Antakya is a valuable tool for genetic counselors when providing information and guidance to individuals and families with a history of this mutation. Understanding the implications of the mutation and the potential risks for future generations is essential for making informed decisions about family planning and medical care.
Used in Pharmaceutical Development:
Although not a direct application, the study of Hemoglobin J Antakya may contribute to the development of new pharmaceuticals or therapies targeting hemoglobin-related disorders. A deeper understanding of the molecular mechanisms underlying this mutation could potentially lead to the discovery of novel treatments or interventions for affected individuals.

Check Digit Verification of cas no

The CAS Registry Mumber 59650-79-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,6,5 and 0 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 59650-79:
(7*5)+(6*9)+(5*6)+(4*5)+(3*0)+(2*7)+(1*9)=162
162 % 10 = 2
So 59650-79-2 is a valid CAS Registry Number.

59650-79-2Upstream product

59650-79-2Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 59650-79-2